Drug makers keen on selection of innovative pharmaceutical firms

Published: 2012-03-14 07:00:00

Updated: 2012-03-14 07:00:00

Aside from their legal action against the government’s plan to slash drug prices in April, all eyes in the domestic pharmaceutical industry are on the Ministry for Health, Welfare and Family Affair's decision on the designation of innovative pharmaceutical firms.

With the ministry’s detailed selection criteria yesterday, small and large pharmaceutical firms are raising their R&D spending ver...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.